Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07485244 · ClinicalTrials.gov registry record
EEG Abnormalities in Adult ICU Patients With High Risk of Delirium
A clinical trial, sponsored by Ceribell.
- Recruiting
- Registry status
- 100
- Enrollment target
NCT07485244: Recruiting study, sponsored by Ceribell.
NCT07485244 is a clinical trial that is actively recruiting participants, run by Ceribell. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07485244 is actively recruiting participants, sponsored by Ceribell.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the prevalence of EEG abnormalities on Ceribell POC EEG in adult medical, surgical, and cardiovascular ICU patients with high risk of delirium
Primary Outcome
Prevalence of EEG abnormalities, including epileptiform and ictal-interictal continuum (IIC) patterns, recorded on the Ceribell EEG System
Interventions
- DEVICE Ceribell EEG System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-04-16 |
| Est. Completion | 2027-09-30 |
What NCT07485244 shows while recruiting
NCT07485244 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Ceribell EEG System is the first listed.
NCT07485244 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07485244 about?
NCT07485244 is a clinical study titled "EEG Abnormalities in Adult ICU Patients With High Risk of Delirium". The purpose of this study is to assess the prevalence of EEG abnormalities on Ceribell POC EEG in adult medical, surgical, and cardiovascular ICU patients with high risk of delirium
What is the current status of trial NCT07485244?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2026-04-16. Estimated completion is 2027-09-30.
What interventions are being tested in trial NCT07485244?
The interventions under investigation include: Ceribell EEG System (DEVICE).
Who is sponsoring clinical trial NCT07485244?
This trial is sponsored by Ceribell, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI